Model predicting 12-month DAS28 remission in the follow-up cohort of 481 early RA patients with moderate–high disease activity at baseline
| Variables | OR (95% CI) |
| DAS28 T0, <5.1=1 | 1.54 (0.94 to 2.51) |
| HAQ T0, <1.5=1 | 1.29 (0.75 to 2.23) |
| VERA, yes=1 | 2.03 (1.25 to 3.30) |
| Anti-CCP+, yes=1 | 1.39 (0.94 to 2.07) |
| Erosions T0, yes=1 | 0.47 (0.29 to 1.08) |
| DMARD within 3 months from disease onset, yes=1 | 1.65 (1.06 to 2.55) |
| Hosmer–Lemeshow test | p=0.59 |
CCP, cyclic citrullinated protein; DAS28, disease activity score in 28 joints; DMARD, disease-modifying antiheumatic drug; HAQ, health assessment questionnaire; T0, baseline; VERA, very early rheumatoid arthritis.
Bold type indicates that the p value is less than 0.05.